Magnesium Sulfate Dosing and Administration
For Severe Pre-eclampsia and Eclampsia
The standard regimen is a 4-6g IV loading dose over 20-30 minutes, followed by 1-2g/hour continuous infusion for 24 hours postpartum. 1, 2, 3
Loading Dose Options
IV-Only Protocol (Preferred when IV access available):
- 4-5g IV diluted in 250mL of 5% dextrose or 0.9% normal saline, infused over 20-30 minutes 2, 3
- Alternatively, dilute to 10-20% concentration and give 4g over 3-4 minutes 3
Pritchard Regimen (When IV pumps unavailable or limited IV access):
- Loading: 4g IV plus 10g IM (5g in each buttock) simultaneously 2, 3
- Maintenance: 5g IM every 4 hours in alternating buttocks 2, 3
- This regimen was validated in the landmark MAGPIE trial showing approximately 50% seizure risk reduction 2
Maintenance Infusion
- Continue 1-2g/hour IV for 24 hours postpartum as the guideline-recommended standard 2, 3
- Alternative approach: May stop after 8g predelivery in select populations, though this requires consideration of local postpartum eclampsia incidence 2
- Do not exceed 30-40g total daily dose 3
Critical Safety Monitoring
Clinical monitoring guides therapy, NOT routine serum levels: 1
- Check patellar reflexes (loss occurs at 3.5-5 mmol/L) 4
- Respiratory rate >12/min (paralysis at 5-6.5 mmol/L) 4
- Urine output ≥30 mL/hour (magnesium is renally excreted) 1
- Oxygen saturation >90% 1
Only check serum magnesium if: 1
- Renal impairment (elevated creatinine)
- Loss of reflexes
- Respiratory depression
- Oliguria develops
Therapeutic range: 1.8-3.0 mmol/L (4.3-7.2 mg/dL) 4
Absolute Contraindications
- Never combine with calcium channel blockers (especially IV/sublingual nifedipine) - causes severe myocardial depression 1
- Severe renal insufficiency: maximum 20g/48 hours with frequent level monitoring 3
Antidote
- Have calcium gluconate 1g IV immediately available to reverse toxicity 2
- Cardiac arrest occurs at >12.5 mmol/L 4
For Severe Acute Asthma
Give 2g IV magnesium sulfate diluted to ≤20% concentration over 20 minutes as adjunct to standard therapy. 5, 2, 3
Specific Protocol
- Dilute 2g in 50mL normal saline 5
- Infuse over 20 minutes 2
- Greatest benefit when FEV1 <20% predicted 5
Evidence Base
- Multicenter RCT showed significantly higher FEV1% predicted at 4 hours when added to standard treatment in patients with FEV1 <30% predicted 5
- No major adverse effects noted 5
- Common side effects: flushing, hypotension, bradycardia 2
Clinical Context
- Use in severe refractory asthma unresponsive to β2-agonists and corticosteroids 2, 6
- Evidence supports use in severe asthma, eclampsia, and torsades de pointes specifically 6
- Rapid 2-minute infusion has been documented as safe and may obviate intubation in status asthmaticus 7
Special Pregnancy Considerations
Fetal Neuroprotection
- Give magnesium sulfate when delivery anticipated before 32 weeks gestation 1
- Reduces cerebral palsy risk (RR 0.68,95% CI 0.54-0.87) without increasing mortality 1
Duration Limits
- Do not continue beyond 5-7 days in pregnancy - causes fetal abnormalities 3
- Standard 24-hour postpartum course is safe 2, 3